TY  - JOUR
AU  - Fernández, Laura
AU  - Carrillo, Eugenia
AU  - Sánchez-Sampedro, Lucas
AU  - Sánchez, Carmen
AU  - Ibarra-Meneses, Ana Victoria
AU  - Jiménez Martínez, María de los Ángeles
AU  - Almeida, Valter dos Anjos
AU  - Esteban, Mariano
AU  - Moreno, Javier
PY  - 2018
DO  - 10.3389/fimmu.2018.00843
SN  - 1664-3224
UR  - https://hdl.handle.net/20.500.14352/96631
T2  - Frontiers in Immunology
AB  - Leishmania-activated C-kinase antigen (LACK) is a highly conserved protein among Leishmania species and is considered a viable vaccine candidate for human leishmaniasis. In animal models, prime-boost vaccination with LACK-expressing plasmids plus...
LA  - eng
PB  - Frontiers Media S.A.
KW  - Antigenicity
KW  - Cytokines
KW  - Hamster
KW  - Leishmania-activated C-kinase antigen
KW  - Vaccine
KW  - Visceral leishmaniasis
TI  - Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters
TY  - journal article
VL  - 9
ER  -